These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 17178300

  • 1. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN, Kahn JB.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [Abstract] [Full Text] [Related]

  • 2. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I, Foote PA, Hausfeld JN.
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH, Memish ZA, Shibl A, Elbashier A, Osoba A.
    East Mediterr Health J; 2005 Nov; 11(1-2):36-44. PubMed ID: 16532669
    [Abstract] [Full Text] [Related]

  • 4. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P, Pessey JJ, Serrano E.
    Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
    [Abstract] [Full Text] [Related]

  • 5. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 6. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 7. Microbiology of recurrent acute rhinosinusitis.
    Brook I, Frazier EH.
    Laryngoscope; 2004 Jan; 114(1):129-31. PubMed ID: 14710008
    [Abstract] [Full Text] [Related]

  • 8. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA, Kopp EJ, Anthony KE, LoCoco JM, Kim SS, Fowler CL.
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 10. Microbiology of sinusitis and the predictive value of throat culture for the aetiology of sinusitis.
    Ilki A, Ulger N, Inanli S, Ozer E, Arikan C, Bakir M, Soyletir G.
    Clin Microbiol Infect; 2005 May; 11(5):407-10. PubMed ID: 15819870
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial treatment of sinusitis.
    Bamberger DM.
    Semin Respir Infect; 1991 Jun; 6(2):77-84. PubMed ID: 1771306
    [Abstract] [Full Text] [Related]

  • 13. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
    Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL.
    Diagn Microbiol Infect Dis; 2008 May; 61(1):13-20. PubMed ID: 18313879
    [Abstract] [Full Text] [Related]

  • 14. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P, Roos K, Tellier G, Rangaraju M, Leroy B.
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [Abstract] [Full Text] [Related]

  • 15. Bacterial findings in acute maxillary sinusitis--European study.
    Penttilä M, Savolainen S, Kiukaanniemi H, Forsblom B, Jousimies-Somer H.
    Acta Otolaryngol Suppl; 1997 Mar; 529():165-8. PubMed ID: 9288300
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
    Zarakolu P, Unal S.
    J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238
    [No Abstract] [Full Text] [Related]

  • 17. The efficacy of cefdinir in acute bacterial rhinosinusitis.
    Hadley JA.
    Expert Opin Pharmacother; 2006 Jun; 7(8):1075-83. PubMed ID: 16722817
    [Abstract] [Full Text] [Related]

  • 18. Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp.
    Kim HJ, Lee K, Yoo JB, Song JW, Yoon JH.
    Acta Otolaryngol; 2006 May; 126(5):489-97. PubMed ID: 16698698
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of culture and polymerase chain reaction methods for the detection of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and middle ear effusions].
    Jbara I, Baysallar M, Kiliç A, Yetişer S, Unay B, Açikel C, Yapar M, Doğanci L.
    Mikrobiyol Bul; 2007 Oct; 41(4):495-502. PubMed ID: 18173067
    [Abstract] [Full Text] [Related]

  • 20. [Augmentin 1 g/125 mg 2 times a day in acute maxillary sinusitis].
    Gehanno P.
    Presse Med; 2000 Sep; 29(26 Suppl):15-7. PubMed ID: 11045114
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.